Bisphenol A and other environmental risk factors for prostate cancer in Hong Kong

Tse, Lap Ah; Lee, Priscilla Ming Yi; Ho, Wai–Kuen; Lam, Augustine; Lee, Man Kei; Ng, Simon Siu Man; He, Yanni; Leung, Ka-sing; Hartle, Jennifer C.; Hu, Howard; Kan, Haidong; Wang, Feng; Ng, Chi Fai

doi:10.1016/j.envint.2017.06.012

Cited by 79 publications

(53 citation statements)

References 27 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…However, the systematic reviews and meta-analysis published before 2017 did not include the most recent studies, which are precisely the only ones that showed high quality according to the NOS [35][36][37][38][39][40]. In addition, they present unsolved problems that justify the realization of the present review.…”

Section: Discussionmentioning

confidence: 91%

“…The pooled estimate for rotating shift work showed a 5% increase in prostate cancer risk (weighted OR 1.05; 95%CI 1.00 to 1.10), with no heterogeneity (I 2 = 0.0%; p = 0.460) ( Table 2). For fixed night shift work, the association with prostate cancer was analyzed in three studies, two of them reporting a significant positive association [25,38]. The pooled estimate was higher than the one obtained for shift work, although it did not achieve statistical significance (weighted OR 1.81; 95%CI 0.86 to 2.76), while heterogeneity was high (I 2 = 81.2%, p = 0.005).…”

Section: Association Between Shift Work and Prostate Cancer: Meta-anamentioning

confidence: 86%

“…The pooled estimate for rotating shift work showed a 5% increase in prostate cancer risk According to the definition of exposure, all the 17 studies included in the present meta-analysis evaluated the relationship between shift work and prostate cancer (seven studies evaluated the relationship between rotating shift work exclusively and prostate cancer; three evaluated the relationship between fixed night shift work and prostate cancer, and only seven evaluated both exposures). Only four studies found a significant positive association, two for night work [25,38] and two for rotating shift work [36,52].…”

Section: Association Between Shift Work and Prostate Cancer: Meta-anamentioning

confidence: 98%

“…A cluster manual search resulted in the location of two additional studies. Thus, a final 18 published studies were included in this review: 12 cohort studies and six case-control studies [25,[38][39][40]48,49]. Among cohort studies, 10 collected exposure at recruitment [35][36][37][50][51][52][53][54][55][56] and two included retrospective information collection [24,52].…”

Section: Data Synthesis and Analysismentioning

confidence: 99%

“…The consideration of only fixed-night work as exposure explains the lower number of studies included in these reviews, although the IARC considered rotating work among circadian cycle disruptors [13]. In addition, the recent publication of high-quality studies in the last years [35][36][37][38][39][40], not included in prior reviews, gives added justification to the performance of an updated systematic review and meta-analysis. Specially, the most recently published work [39], represents one of the largest and most informative case-control studies to date with detailed exposure information.…”

Section: Introductionmentioning

confidence: 99%

See 4 more Smart Citations

Shift Work and Prostate Cancer: An Updated Systematic Review and Meta-Analysis

Rivera-Izquierdo

Martínez-Ruiz

Castillo-Ruiz

et al. 2020

IJERPH

View full text Add to dashboard Cite

The International Agency of Research in Cancer (IARC) has recently confirmed shift work as a type 2A carcinogen. The results presented in published epidemiological studies regarding prostate cancer are inconsistent and the association remains controversial. The aims of this study were: (a) to investigate the possible association between shift work and prostate cancer incidence, identifying possible sources of heterogeneity; and (b) to analyze the potential effect of publication bias. A search for cohort and case-control studies published from January 1980 to November 2019 was conducted. The quality of the articles was assessed using the Newcastle–Ottawa Scale. Pooled OR were calculated using random-effects models. Heterogeneity was evaluated using Cochran’s Q test and data were stratified by potential sources of heterogeneity. Publication bias was analyzed. Eighteen studies were included. No association was found between rotating/night-shift work and prostate cancer, pooled OR 1.07 (95%CI 0.99 to 1.15), I2 = 45.7%, p = 0.016. Heterogeneity was eliminated when only cohort studies (pooled OR 1.03; 95%CI 0.96 to 1.10; I2 = 18.9%, p = 0.264) or high-quality studies (pooled OR 0.99; 95%CI 0.89 to 1.08; I2 = 0.0%, p = 0.571) were considered. A publication bias was detected. An association between shift work and prostate cancer cannot be confirmed with the available current data. Future analytical studies assessing more objective homogeneous exposure variables still seem necessary.

show abstract

Section: Discussionmentioning

confidence: 91%

Section: Association Between Shift Work and Prostate Cancer: Meta-anamentioning

confidence: 86%

Section: Association Between Shift Work and Prostate Cancer: Meta-anamentioning

confidence: 98%

Section: Data Synthesis and Analysismentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

Shift Work and Prostate Cancer: An Updated Systematic Review and Meta-Analysis

Rivera-Izquierdo

Martínez-Ruiz

Castillo-Ruiz

et al. 2020

IJERPH

View full text Add to dashboard Cite

show abstract

Green tea (Camellia sinensis) for the prevention of cancer

Filippini

Malavolti

Borrelli

et al. 2020

Cochrane Database of Systematic Reviews

151

View full text Add to dashboard Cite

Evaluating endocrine disrupting chemicals: A perspective on the novel assessments in CLARITY‐BPA

Howdeshell,

Beverly,

Blain

et al. 2023

Birth Defects Research

View full text Add to dashboard Cite

BackgroundThe Consortium Linking Academic and Regulatory Insights on Bisphenol A Toxicity (CLARITY‐BPA) was a collaborative research effort to better link academic research with governmental guideline studies. This review explores the secondary goal of CLARITY‐BPA: to identify endpoints or technologies from CLARITY‐BPA and prior/concurrent literature from these laboratories that may enhance the capacity of rodent toxicity studies to detect endocrine disrupting chemicals (EDCs).MethodsA systematic literature search was conducted with search terms for BPA and the CLARITY‐BPA participants. Relevant studies employed a laboratory rodent model and reported results on 1 of the 10 organs/organ systems evaluated in CLARITY‐BPA (brain and behavior, cardiac, immune, mammary gland, ovary, penile function, prostate gland and urethra, testis and epididymis, thyroid hormone and metabolism, and uterus). Study design and findings were summarized, and a risk‐of‐bias assessment was conducted.ResultsSeveral endpoints and methods were identified as potentially helpful to detect effects of EDCs. For example, molecular and quantitative morphological approaches were sensitive in detecting alterations in early postnatal development of the brain, ovary, and mammary glands. Hormone challenge studies mimicking human aging reported increased susceptibility of the prostate to disease following developmental BPA exposure. Statistical analyses for nonmonotonic dose responses, and computational approaches assessing multiple treatment‐related outcomes concurrently in linked hormone‐sensitive organ systems, reported effects at low BPA doses.ConclusionsThis review provided an opportunity to evaluate the unique insights provided by nontraditional assessments in CLARITY‐BPA to identify technologies and endpoints to enhance detection of EDCs in future studies.

show abstract

Bisphenol A and other environmental risk factors for prostate cancer in Hong Kong

Cited by 79 publications

References 27 publications

Shift Work and Prostate Cancer: An Updated Systematic Review and Meta-Analysis

Shift Work and Prostate Cancer: An Updated Systematic Review and Meta-Analysis

Green tea (Camellia sinensis) for the prevention of cancer

Evaluating endocrine disrupting chemicals: A perspective on the novel assessments in CLARITY‐BPA

Contact Info

Product

Resources

About